![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RFC3 |
Gene summary for RFC3 |
![]() |
Gene information | Species | Human | Gene symbol | RFC3 | Gene ID | 5983 |
Gene name | replication factor C subunit 3 | |
Gene Alias | RFC38 | |
Cytomap | 13q13.2 | |
Gene Type | protein-coding | GO ID | GO:0000731 | UniProtAcc | A0A024RDQ8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5983 | RFC3 | P2T-E | Human | Esophagus | ESCC | 1.04e-11 | 3.22e-01 | 0.1177 |
5983 | RFC3 | P5T-E | Human | Esophagus | ESCC | 2.72e-10 | 1.64e-01 | 0.1327 |
5983 | RFC3 | P8T-E | Human | Esophagus | ESCC | 1.14e-07 | 2.39e-01 | 0.0889 |
5983 | RFC3 | P10T-E | Human | Esophagus | ESCC | 2.09e-11 | 2.88e-01 | 0.116 |
5983 | RFC3 | P12T-E | Human | Esophagus | ESCC | 1.01e-02 | 7.42e-02 | 0.1122 |
5983 | RFC3 | P16T-E | Human | Esophagus | ESCC | 8.66e-05 | 1.24e-01 | 0.1153 |
5983 | RFC3 | P21T-E | Human | Esophagus | ESCC | 1.09e-02 | 1.25e-01 | 0.1617 |
5983 | RFC3 | P22T-E | Human | Esophagus | ESCC | 9.87e-03 | 7.34e-02 | 0.1236 |
5983 | RFC3 | P24T-E | Human | Esophagus | ESCC | 1.67e-05 | 1.64e-01 | 0.1287 |
5983 | RFC3 | P26T-E | Human | Esophagus | ESCC | 4.49e-08 | 1.25e-01 | 0.1276 |
5983 | RFC3 | P28T-E | Human | Esophagus | ESCC | 1.17e-13 | 1.97e-01 | 0.1149 |
5983 | RFC3 | P31T-E | Human | Esophagus | ESCC | 8.74e-11 | 1.90e-01 | 0.1251 |
5983 | RFC3 | P32T-E | Human | Esophagus | ESCC | 1.13e-07 | 1.95e-01 | 0.1666 |
5983 | RFC3 | P36T-E | Human | Esophagus | ESCC | 2.40e-03 | 1.67e-01 | 0.1187 |
5983 | RFC3 | P49T-E | Human | Esophagus | ESCC | 4.04e-03 | 6.12e-01 | 0.1768 |
5983 | RFC3 | P52T-E | Human | Esophagus | ESCC | 1.13e-07 | 1.76e-01 | 0.1555 |
5983 | RFC3 | P56T-E | Human | Esophagus | ESCC | 3.41e-04 | 5.19e-01 | 0.1613 |
5983 | RFC3 | P62T-E | Human | Esophagus | ESCC | 7.81e-03 | 1.44e-01 | 0.1302 |
5983 | RFC3 | P65T-E | Human | Esophagus | ESCC | 4.76e-02 | 1.09e-01 | 0.0978 |
5983 | RFC3 | P76T-E | Human | Esophagus | ESCC | 2.69e-06 | 2.04e-01 | 0.1207 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00062604 | Esophagus | ESCC | DNA replication | 181/8552 | 260/18723 | 3.55e-15 | 2.05e-13 | 181 |
GO:005105215 | Esophagus | ESCC | regulation of DNA metabolic process | 232/8552 | 359/18723 | 2.40e-13 | 1.13e-11 | 232 |
GO:007189716 | Esophagus | ESCC | DNA biosynthetic process | 127/8552 | 180/18723 | 1.04e-11 | 3.85e-10 | 127 |
GO:005105417 | Esophagus | ESCC | positive regulation of DNA metabolic process | 139/8552 | 201/18723 | 1.20e-11 | 4.33e-10 | 139 |
GO:200057319 | Esophagus | ESCC | positive regulation of DNA biosynthetic process | 56/8552 | 66/18723 | 4.51e-11 | 1.45e-09 | 56 |
GO:2000278110 | Esophagus | ESCC | regulation of DNA biosynthetic process | 81/8552 | 106/18723 | 9.81e-11 | 2.96e-09 | 81 |
GO:00062612 | Esophagus | ESCC | DNA-dependent DNA replication | 100/8552 | 151/18723 | 2.61e-07 | 3.94e-06 | 100 |
GO:00062754 | Esophagus | ESCC | regulation of DNA replication | 73/8552 | 107/18723 | 1.97e-06 | 2.28e-05 | 73 |
GO:003239214 | Esophagus | ESCC | DNA geometric change | 62/8552 | 90/18723 | 7.02e-06 | 7.04e-05 | 62 |
GO:003250813 | Esophagus | ESCC | DNA duplex unwinding | 58/8552 | 84/18723 | 1.23e-05 | 1.14e-04 | 58 |
GO:0090329 | Esophagus | ESCC | regulation of DNA-dependent DNA replication | 30/8552 | 46/18723 | 5.91e-03 | 2.18e-02 | 30 |
GO:00062603 | Oral cavity | OSCC | DNA replication | 159/7305 | 260/18723 | 3.25e-13 | 1.59e-11 | 159 |
GO:005105210 | Oral cavity | OSCC | regulation of DNA metabolic process | 207/7305 | 359/18723 | 4.45e-13 | 2.17e-11 | 207 |
GO:005105414 | Oral cavity | OSCC | positive regulation of DNA metabolic process | 126/7305 | 201/18723 | 8.12e-12 | 3.01e-10 | 126 |
GO:00718979 | Oral cavity | OSCC | DNA biosynthetic process | 106/7305 | 180/18723 | 4.86e-08 | 8.95e-07 | 106 |
GO:00323925 | Oral cavity | OSCC | DNA geometric change | 59/7305 | 90/18723 | 3.03e-07 | 4.63e-06 | 59 |
GO:200027817 | Oral cavity | OSCC | regulation of DNA biosynthetic process | 67/7305 | 106/18723 | 3.85e-07 | 5.75e-06 | 67 |
GO:00325083 | Oral cavity | OSCC | DNA duplex unwinding | 55/7305 | 84/18723 | 8.05e-07 | 1.12e-05 | 55 |
GO:200057316 | Oral cavity | OSCC | positive regulation of DNA biosynthetic process | 44/7305 | 66/18723 | 4.91e-06 | 5.57e-05 | 44 |
GO:00062611 | Oral cavity | OSCC | DNA-dependent DNA replication | 84/7305 | 151/18723 | 2.46e-05 | 2.30e-04 | 84 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa034204 | Oral cavity | OSCC | Nucleotide excision repair | 49/3704 | 63/8465 | 3.48e-08 | 2.91e-07 | 1.48e-07 | 49 |
hsa03030 | Oral cavity | OSCC | DNA replication | 31/3704 | 36/8465 | 1.70e-07 | 1.19e-06 | 6.03e-07 | 31 |
hsa03410 | Oral cavity | OSCC | Base excision repair | 32/3704 | 44/8465 | 9.11e-05 | 3.25e-04 | 1.65e-04 | 32 |
hsa03430 | Oral cavity | OSCC | Mismatch repair | 19/3704 | 23/8465 | 1.55e-04 | 5.34e-04 | 2.72e-04 | 19 |
hsa0342011 | Oral cavity | OSCC | Nucleotide excision repair | 49/3704 | 63/8465 | 3.48e-08 | 2.91e-07 | 1.48e-07 | 49 |
hsa030301 | Oral cavity | OSCC | DNA replication | 31/3704 | 36/8465 | 1.70e-07 | 1.19e-06 | 6.03e-07 | 31 |
hsa034101 | Oral cavity | OSCC | Base excision repair | 32/3704 | 44/8465 | 9.11e-05 | 3.25e-04 | 1.65e-04 | 32 |
hsa034301 | Oral cavity | OSCC | Mismatch repair | 19/3704 | 23/8465 | 1.55e-04 | 5.34e-04 | 2.72e-04 | 19 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RFC3 | SNV | Missense_Mutation | rs769043955 | c.124N>A | p.Gly42Arg | p.G42R | P40938 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
RFC3 | SNV | Missense_Mutation | novel | c.562N>C | p.Ser188Arg | p.S188R | P40938 | protein_coding | tolerated(0.08) | benign(0.248) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
RFC3 | SNV | Missense_Mutation | rs41553716 | c.583G>A | p.Val195Met | p.V195M | P40938 | protein_coding | deleterious(0.01) | possibly_damaging(0.828) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
RFC3 | SNV | Missense_Mutation | c.147N>T | p.Lys49Asn | p.K49N | P40938 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
RFC3 | SNV | Missense_Mutation | novel | c.280N>A | p.Glu94Lys | p.E94K | P40938 | protein_coding | deleterious(0) | probably_damaging(0.984) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
RFC3 | SNV | Missense_Mutation | novel | c.1021N>A | p.Ala341Thr | p.A341T | P40938 | protein_coding | tolerated(0.25) | benign(0.003) | TCGA-EY-A215-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
RFC3 | deletion | Frame_Shift_Del | c.526_553delNNNNNNNNNNNNNNNNNNNNNNNNNNNN | p.Arg176LeufsTer21 | p.R176Lfs*21 | P40938 | protein_coding | TCGA-AP-A0LD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |||
RFC3 | SNV | Missense_Mutation | novel | c.659N>T | p.Cys220Phe | p.C220F | P40938 | protein_coding | deleterious(0.02) | benign(0.003) | TCGA-55-7281-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | PD |
RFC3 | SNV | Missense_Mutation | novel | c.409G>T | p.Val137Phe | p.V137F | P40938 | protein_coding | deleterious(0) | probably_damaging(0.928) | TCGA-22-1002-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
RFC3 | SNV | Missense_Mutation | novel | c.523A>G | p.Ile175Val | p.I175V | P40938 | protein_coding | tolerated(0.25) | benign(0.122) | TCGA-56-8504-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |